Pharm2 1 T2DM Agents pt4 Flashcards

1
Q

Canagliflozin (Cana) became the first SGLT2 inhibitor to be approved in the US in

A

March 2013

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Canagliflozin (Cana) should not be initiated in patients with an

A

eGFR <45 mL/min/1.73 m2 - Severe renal impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cana efficacy of lowering HbA1C:

A

1.0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Canagliflozin AE/SE

A

female genital mycotic infections, uncircumsized men are also at risk of these yeast infections
urinary tract infection
increased urination, dehydration
Dehydration makes them pee less, and this relates to the UTI’s (current understanding of this new drug)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When Cana was first marketed, who was it marketed to? .

A

Endocrinologists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Non-insulin SQ Agents

A

Incretin-mimetics (these are injectable agents)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do Incretin-mimetics work?

What’s their route of admin?

A

Enhances glucose-dependent insulin secretion by the pancreatic beta-cell, suppresses inappropriately elevated glucagon secretion, and slows gastric emptying (feel full longer). Works only when glucose is in the gut (not in the serum)
SQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The only SQ agent for T2DM that does not contain insulin

A

Incretin-mimetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ex of Incretin-mimetics.

Route of admin, how many times per day/where/when?

A

Exenatide (Byetta®)
SQ into upper thigh, abdomen or arm within 60 minutes of AM and PM meals
Think of its name, it’s taken BID.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diabetes mediations are titrated up slowly because:

A

of nausea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Formulations that exist of Exenatide (Incretin-mimetic SQ)

A

There’s a 2x day, 1x day, and 1x week version. Soon there will be a 1x month, and in a few months there will also be a 1x year! The longer lasting formulations lower the A1C more than the shorter ones do.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The longer lasting formulations lower the A1C more than the shorter ones do.
How do they do this?

A

Their coating. Absorbable stitches in a microsphere, impregnate each one with the drug. You inject it, and it’s absorbed at the appropriate rate. Just caution patients that these long acting versions leave a little bump on their skin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Exenatide: Cautions, Precautions, Pregnancy

A

Cautions: rare cases of acute pancreatitis reported (only b/c this is given to patients with higher TG in the first place, which puts them at higher risk of pancreatitis)
Precautions: severe stomach disorders
Pregnancy: switch to insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What lab values are most abnormal (besides sugars) in a DM patient?

A

Triglycerides

High risk of pancreatitis with high trigs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Exenatide: Side effects, Efficacy lowering HbA1C in monotherapy

A

Side effects: GI disturbances (esp. nausea), GERD, decreased appetite
Average 8 pound weight loss
Efficacy: 0.8 – 0.9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Exenatide’s weight loss pleateaus after ~____.
And this helps motivate patients.
Bad news is it doesn’t lower A1C very much. But if they continue weight loss, that continues to lower the A1C

A

3-6 months

17
Q

Multiple combinations exist of these classes (must have diff mech of action). Name 4

A

TZD + SU
Biguanide + TZD
Biguanide + SU
Biguanide + DPP4-Inhibitor

18
Q

Once combination therapy for T2DM fails…

A

move to insulin